396 related articles for article (PubMed ID: 20564754)
21. Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update.
Mao Y; Ma S; Liu C; Liu X; Su M; Li D; Li Y; Chen G; Chen J; Chen J; Zhao J; Guo X; Tang J; Zhuge Y; Xie Q; Xie W; Lai R; Cai D; Cai Q; Zhi Y; Li X;
Hepatol Int; 2024 Apr; 18(2):384-419. PubMed ID: 38402364
[TBL] [Abstract][Full Text] [Related]
22. When Is Suspected Drug-Induced Liver Injury (DILI) Not DILI? An Analysis of Unlikely Cases From the Drug-Induced Liver Injury Network.
Barritt AS; Barnhart H; Gu J; Dellinger A; Rudnick S; Bonkovsky HL;
Am J Gastroenterol; 2023 Dec; 118(12):2301-2304. PubMed ID: 37311048
[TBL] [Abstract][Full Text] [Related]
23. A Text Searching Tool to Identify Patients with Idiosyncratic Drug-Induced Liver Injury.
Heidemann L; Law J; Fontana RJ
Dig Dis Sci; 2017 Mar; 62(3):615-625. PubMed ID: 26597192
[TBL] [Abstract][Full Text] [Related]
24. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury.
Chalasani NP; Hayashi PH; Bonkovsky HL; Navarro VJ; Lee WM; Fontana RJ;
Am J Gastroenterol; 2014 Jul; 109(7):950-66; quiz 967. PubMed ID: 24935270
[TBL] [Abstract][Full Text] [Related]
25. Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?
Danan G; Teschke R
Drug Saf; 2018 Aug; 41(8):735-743. PubMed ID: 29502198
[TBL] [Abstract][Full Text] [Related]
26. [Chinese guideline for diagnosis and management of drug-induced liver injury (2023 version)].
;
Zhonghua Gan Zang Bing Za Zhi; 2023 Apr; 31(4):355-384. PubMed ID: 37248976
[TBL] [Abstract][Full Text] [Related]
27. Reliability of causality assessment for drug, herbal and dietary supplement hepatotoxicity in the Drug-Induced Liver Injury Network (DILIN).
Hayashi PH; Barnhart HX; Fontana RJ; Chalasani N; Davern TJ; Talwalkar JA; Reddy KR; Stolz AA; Hoofnagle JH; Rockey DC
Liver Int; 2015 May; 35(5):1623-32. PubMed ID: 24661785
[TBL] [Abstract][Full Text] [Related]
28. Drug induced liver injury with analysis of alternative causes as confounding variables.
Teschke R; Danan G
Br J Clin Pharmacol; 2018 Jul; 84(7):1467-1477. PubMed ID: 29607530
[TBL] [Abstract][Full Text] [Related]
29. Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase.
Xu HM; Chen Y; Xu J; Zhou Q
World J Gastroenterol; 2012 Nov; 18(41):5972-8. PubMed ID: 23139615
[TBL] [Abstract][Full Text] [Related]
30. ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury.
Chalasani NP; Maddur H; Russo MW; Wong RJ; Reddy KR;
Am J Gastroenterol; 2021 May; 116(5):878-898. PubMed ID: 33929376
[TBL] [Abstract][Full Text] [Related]
31. Drug-induced liver injury: Pathogenesis, epidemiology, clinical features, and practical management.
Björnsson HK; Björnsson ES
Eur J Intern Med; 2022 Mar; 97():26-31. PubMed ID: 34772600
[TBL] [Abstract][Full Text] [Related]
32. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.
Teschke R
Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1169-1187. PubMed ID: 30354694
[TBL] [Abstract][Full Text] [Related]
33. Liver safety assessment: required data elements and best practices for data collection and standardization in clinical trials.
Avigan MI; Bjornsson ES; Pasanen M; Cooper C; Andrade RJ; Watkins PB; Lewis JH; Merz M
Drug Saf; 2014 Nov; 37 Suppl 1(Suppl 1):S19-31. PubMed ID: 25352325
[TBL] [Abstract][Full Text] [Related]
34. [Drug-induced liver injury: diagnosis of exclusion].
Maev IV; Polunina TE
Ter Arkh; 2023 Oct; 95(8):611-620. PubMed ID: 38158894
[TBL] [Abstract][Full Text] [Related]
35. Drug-induced liver injury.
Leise MD; Poterucha JJ; Talwalkar JA
Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
[TBL] [Abstract][Full Text] [Related]
36. Drug-Induced Liver Injury: Highlights of the Recent Literature.
Real M; Barnhill MS; Higley C; Rosenberg J; Lewis JH
Drug Saf; 2019 Mar; 42(3):365-387. PubMed ID: 30343418
[TBL] [Abstract][Full Text] [Related]
37. Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature.
Sarges P; Steinberg JM; Lewis JH
Drug Saf; 2016 Sep; 39(9):801-21. PubMed ID: 27142208
[TBL] [Abstract][Full Text] [Related]
38. Drug-induced liver injury: present and future.
Suk KT; Kim DJ
Clin Mol Hepatol; 2012 Sep; 18(3):249-57. PubMed ID: 23091804
[TBL] [Abstract][Full Text] [Related]
39. Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study.
Molleston JP; Fontana RJ; Lopez MJ; Kleiner DE; Gu J; Chalasani N;
J Pediatr Gastroenterol Nutr; 2011 Aug; 53(2):182-9. PubMed ID: 21788760
[TBL] [Abstract][Full Text] [Related]
40. An Approach to Drug-Induced Liver Injury from the Geriatric Perspective.
Lee BT; Odin JA; Grewal P
Curr Gastroenterol Rep; 2021 Apr; 23(4):6. PubMed ID: 33846832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
